Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Doubl... von Navari, Rudolph M, Le-Rademacher, Jennifer, Smieliauskas, Fabrice, Ruddy, Kathryn J, James Saphner, Thomas, Liu, Heshan, Harlos, Elizabeth, Onitilo, Adedayo A, Giridhar, Karthik, Paul Singh, Preet, Reddy, Pavan S, Chow, Selina, Kruter, Flavio, Raptis, George, Loprinzi, Charles L

Volltext

Effect on clinical trial participation by integration of a clinical pathway program into an electronic health record (EHR) von Shamah, Corey J., Saphner, Thomas James

Volltext

Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III ran... von Navari, Rudolph M., Le-Rademacher, Jennifer, Smieliauskas, Fabrice, Ruddy, Kathryn Jean, Saphner, Thomas James, Liu, Heshan, Harlos, Beth, Onitilo, Adedayo A., Giridhar, Karthik, Singh, Preet Paul, Reddy, Pavan S., Kruter, Flavio, Raptis, George, Loprinzi, Charles L.

Volltext

Integration of a clinical pathways software into an EHR in a large, multisite, hospital-affiliated community oncology setting von Shamah, Corey J., Saphner, Thomas James, Frick, Jacob C., Huibregtse, Carol, Stiemke, Gail S.

Volltext

Integration of a clinical pathways software into an EHR in a large, multisite, hospital affiliated community oncology setting von Shamah, Corey J., Saphner, Thomas James, Frick, Jacob C., Huibregtse, Carol, Stiemke, Gail S.

Volltext

Impact of clinical risk category on prognosis and prediction of chemotherapy benefit in early breast cancer (EBC) by age and the 21-gene recurrence score (RS) in TAILORx von Sparano, Joseph A., Gray, Robert James, Makower, Della F., Lively, Tracy G., Saphner, Thomas James, Keane, Maccon M., Gomez, Henry Leonidas, Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Toppmeyer, Deborah, Brufsky, Adam, Goetz, Matthew P., Hayes, Daniel F., Dees, Elizabeth Claire, Pritchard, Kathleen I., Geyer, Charles E., Olson, John A., Albain, Kathy S., Sledge, George W.

Volltext

TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate progn... von Sparano, Joseph A., Gray, Robert James, Wood, William C., Makower, Della F., Lively, Tracy G., Saphner, Thomas James, Keane, Maccon M., Gomez, Henry Leonidas, Reddy, Pavan S., Goggins, Timothy F, Mayer, Ingrid A., Toppmeyer, Deborah, Brufsky, Adam, Goetz, Matthew P., Hayes, Daniel F., Dees, Elizabeth Claire, Pritchard, Kathleen I., Geyer, Charles E., Olson, John A., Sledge, George W.

Volltext

A randomized phase III double-blinded placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-overexpressing meta... von Arteaga, Carlos L., Mayer, Ingrid A., O'Neill, Anne M., Swaby, Ramona F., Alpaugh, R. Katherine, Yang, Ximing J, Wagner, Lynne I., Meropol, Neal J., Saphner, Thomas James, Jahanzeb, Mohammad, Perez, Edith A., Lin, Nancy U., Sledge, George W.

Volltext

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Perez, Edith A, Olson, John A, Zujewski, JoAnne, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Atkins, James N, Berenberg, Jeffrey L, Sledge, George W

Volltext

A Phase II Trial of Gemcitabine, 5-Fluorouracil and Leucovorin in Advanced Esophageal Carcinoma von Morgan-Meadows, Sherry, Mulkerin, Daniel, Berlin, Jordan D., Kim, KyungMann, Bailey, Howard, Saphner, Thomas, Jumonville, Alcee, Hansen, Richard, Ahuja, Harish, McFarland, Thomas, Thomas, James P.

Volltext

21-Day oral etoposide for metastatic breast cancer : A phase II study and review of the literature von SAPHNER, T, WELLER, E. A, TORMEY, D. C, PANDYA, K. J, FALKSON, C. I, STEWART, J, ROBERT, N. J

Volltext